Cinemark Holdings, Inc. research snapshot
CNK AI stock analysis reads Cinemark Holdings as a movie exhibition business benefiting from a strong 2025-2026 box office recovery cycle but facing structural streaming disruption, elevated debt, and a compressed window between content suppliers and digital platforms. At the July 12, 2026 data cutoff, CNK traded near $29.04 with a verified market capitalization of $3.39 billion. This page uses scenario ranges and source checks, not a certain stock price prediction, and is for informational use only.
Current price
$29.04
Market cap
$3.39 billion
AI score
63 / 100
Rating
Cyclical recovery play, box office momentum vs. structural streaming risk and high debt leverage
Trend status
Up 25% YTD, testing near $30 resistance with strong summer box office
Data cutoff (updated weekly)
July 12, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Cinemark operates one of the largest movie theatre chains in the Americas with 497 locations and over 5,600 screens. Revenue comes from ticket sales, concessions, screen advertising, and loyalty programs. The business is asset-heavy and cyclical. | Medium |
| Moat | Moat is local and practical: prime real estate locations, long-term lease control, Cinemark XD and premium large-format screens, Movie Club loyalty subscribers at 1.45 million, brand recognition, and scale purchasing power for concessions. | Medium |
| Management | Founder Lee Roy Mitchell chairs the board. CEO Sean Gamble has led post-COVID recovery, restarted the dividend, and invested in premium formats and loyalty. Capital allocation is constrained by debt service obligations. | Medium |
| Financial trend | Revenue recovered from $1.51 billion in 2021 to $3.115 billion in FY2025. Net income turned positive in 2023 but declined from $309.7 million in FY2024 to $138.2 million in FY2025. Q1 2026 posted a net loss of $6.4 million. | High |
| Valuation | At $29.04, CNK trades at 24.6x trailing EPS of $1.18, 13.6x forward earnings, 1.23x revenue, 9.1x book value, and 14.9x free cash flow. The forward multiple implies the market expects a significant earnings recovery. | Medium-high |
| Technical trend | The stock is up roughly 25% year to date and has recovered from its 52-week low of $21.60. It is testing the $30 resistance zone near analyst consensus and high-volume trading levels. | Medium |
| Risk level | Elevated. Key risks include streaming substitution, film window compression, high debt-to-equity of 767%, annual interest expense near $164 million, Q1 2026 net loss, content supply interruptions, and consumer discretionary spending sensitivity. | Medium-high |
| AI confidence | High for market cap, price, share count, FY2025 filings, and common ratios. Medium for forward scenarios and technical chart levels. | High data confidence |
| Investment certainty | Medium-low due to debt overhang, structural industry risk, and declining net income trend. The page frames scenarios and monitoring rules, not a buy or sell instruction. | Medium-low |
CNK AI stock forecast
The CNK AI stock forecast uses scenario math around the $29.04 quote and FY2025 diluted EPS of $1.18. The audited three-year framework produced a bearish area near $12, a base area near $25, and a bullish area near $41 before dividends, reflecting both the recovery opportunity and the structural risk to exhibition economics.
$37 to $44
More likely if summer 2026 and the 2026-2027 film slate drive sustained box office momentum, Cinemark maintains concession margins, Latin America performs well, debt paydown continues, and the market assigns a 20x multiple to recovered earnings of $2.00+ per share.
$22 to $28
More likely if box office stabilizes near current levels, the company grows EPS modestly through pricing and premium formats, but high debt service and streaming pressure keep the earnings multiple in the 14x to 16x range on improved but not fully recovered earnings.
$10 to $14
More likely if the box office cycle turns down, the theatrical window shortens further, streaming takes more share, earnings fail to recover, and the market reprices the stock near a distressed 10x multiple on stagnant or declining earnings.
CNK AI technical analysis
CNK AI technical analysis shows a stock in a medium-term recovery from its 52-week low of $21.60, now testing the $30 resistance zone as of the July 12, 2026 data cutoff. The stock gained roughly 28% over the past six months, driven by summer box office optimism and the July 9 Goldman Sachs upgrade from Neutral to Buy with a $30 price target.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $29.04 | Quote snapshots around the July 12, 2026 cutoff placed CNK near $29.04 after a 1.9% daily decline. |
| Near support | $26.00 to $28.00 | The $26 to $28 zone represents prior consolidation levels and Morgan Stanleys previous price target before the upgrade cycle. |
| Key support | $21.60 | The 52-week low is the strongest support level. A break below this would confirm a failed recovery. |
| Near resistance | $30.00 | Goldmans upgraded $30 price target and the round number both create a resistance zone. A close above $30 with volume would be constructive. |
| Major resistance | $34.73 to $37.00 | The 52-week high of $34.73 and the high-end analyst target of $37 form the upper resistance band. |
| Momentum | TradingView rating: Neutral | TradingView rated CNK as neutral with mixed buy and sell signals as of the data cutoff, reflecting the indecision near resistance. |
| Short interest | 7.62% of float | Short interest of 7.62% represents 3.11 days to cover. Elevated short interest can add volatility but also squeeze potential on positive catalysts. |
| Recent performance | +25% YTD, -10% 1-month | The stock pulled back roughly 10% in the month before the cutoff after strong YTD gains, suggesting profit-taking near resistance. |
| Invalidation | Close below $26 | A decisive close below the $26 support zone would weaken the recovery thesis established since the 52-week low. |
CNK AI trading strategy
The CNK AI trading strategy is a rules-based research framework for monitoring a cyclical movie exhibition stock with debt leverage and structural risk. It is not personal advice and should be paired with fresh chart data, quarterly box office trends, debt metrics, and a defined invalidation level.
Watch for CNK to clear $30 on above-average volume supported by a strong film slate update or earnings beat. A sustained move toward the $34 to $37 zone would require confirmation of box office momentum, margin stability, and debt reduction progress.
A close below $26 or failure to hold above $30 after an earnings catalyst should invalidate the breakout setup.
If CNK pulls back toward the $26 to $28 zone without a negative earnings revision, compare the risk-reward with upcoming film slate quality, industry box office data, and debt maturity schedule before assuming support holds.
Avoid averaging down without a strict maximum loss rule because exhibition stocks can gap on film slate news, streaming announcements, or box office misses.
Track quarterly box office revenue trends, concession per-patron metrics, Latin America performance, total attendance, average ticket price, debt paydown progress, free cash flow, and dividend coverage.
Reduce position confidence if net income and free cash flow decline year-over-year, debt ratios worsen, or streaming platforms further compress the theatrical window.
Investment research summary
Cinemark sells movie tickets, popcorn, and soda in purpose-built theatres with stadium seating and premium screens. Customers pay for the theatrical experience, but the same content is increasingly available on streaming platforms at home.
The moat is local rather than global. Prime theatre locations, long-term leases, Cinemark XD premium screens, Movie Club loyalty subscribers, concession brand recognition, and scale in Latin America create barriers, but no single factor prevents a consumer from waiting for streaming.
The thesis fails if streaming reduces theatrical attendance structurally, film window compression reduces the exclusivity period, a recession cuts discretionary entertainment spending, or debt service consumes cash flow during a box office downturn.
Management should be judged by box office recovery execution, premium format ROI, Latin America performance, debt reduction progress, loyalty program monetization, and whether capital allocation prioritizes deleveraging over shareholder returns.
Movie exhibition sits between Hollywood content suppliers and consumer entertainment choice. The industry faces secular pressure from streaming but benefits from occasional content super-cycles, premium format adoption, and the social event nature of theatrical releases.
At roughly 24.6x trailing EPS and 13.6x forward EPS, the stock prices in a significant earnings recovery. Margin of safety is limited given high debt, declining FY2025 net income, and structural industry risk. The forward multiple suggests the recovery must materialize to justify the current price.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CNK price | $29.04 | Google Finance quote snapshot | July 12, 2026 |
| Market capitalization | $3.39 billion, verified as $29.04 x 116.79 million shares | financial_rigor.py market cap verification | July 12, 2026 |
| FY2025 revenue | $3.115 billion, cross-checked against rounded third-party $3.12 billion figures | Cinemark FY2025 Form 10-K via Barchart | July 12, 2026 |
| FY2025 net income | $138.2 million, diluted EPS of $1.04 | Cinemark FY2025 Form 10-K via Barchart | July 12, 2026 |
| FY2025 operating cash flow | $408.1 million | Cinemark FY2025 Form 10-K via Barchart | July 12, 2026 |
| Cash and debt | Total debt approximately $4.02 billion, debt-to-equity ratio 767% | Cinemark FY2025 Form 10-K via Yahoo Finance | July 12, 2026 |
| Q1 2026 results | $643.1 million revenue, net loss of $6.4 million | Cinemark Q1 2026 earnings via Google Finance | July 12, 2026 |
| Dividend | $0.36 per share annually, 1.24% yield | Google Finance dividend data | July 12, 2026 |
| Analyst consensus | 5 Buy, 2 Hold, 1 Sell. Average target $34.75 | Google Finance analyst ratings | July 12, 2026 |
| Valuation snapshot | PE TTM 24.6x, Forward PE 13.6x, PS 1.23x, PB 9.07x, EV/EBITDA 11.02x | Yahoo Finance key statistics | July 12, 2026 |
This page is an informational research tool only and is not investment advice, financial advice, or a recommendation to buy or sell CNK stock. Forecast scenarios are based on available public data, technical snapshots, and stated assumptions as of the data cutoff date and may be wrong. Always verify current filings, prices, risks, and personal suitability before making financial decisions.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
